FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Transmissible Spongiform Encephalopathies Advisory Committee

horizontal rule

February 20, 2003 Meeting

Date and Time:

The meeting will be held on February 20, 2003; 8:00 a.m. to 5:30 p.m.

Location:

Holiday Inn, Ballroom, 2 Montgomery Village Avenue, Gaithersburg, MD 301-948-8900

Contact Person:

William Freas, Ph.D., or Sheila D. Langford, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12392. Please call the Information Line for up-to-date information on this meeting.

Agenda:

The committee will listen to updates on: implementation of the variant Creutzfeldt-Jakob disease (vCJD) guidance and its affect on blood supply, and an update on bovine spongiform encephalopathy epidemiology and food chain controls. The committee will then discuss consideration of labeling claims for transmissible spongiform encephalopathy (TSE) agent clearance in plasma derivatives.

Oral Presentations:

From approximately 10:10 a.m. to 10:30 a.m., and 3:00 p.m. to 3:40 p.m. oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before February 13, 2003.

 

 
horizontal rule